Severe COVID Infection: Patient Characteristics, Outcome Indicators and Long COVID

Infectious Diseases
Curriculum:
Severe COVID Infection: Patient Characteristics, Outcome Indicators and Long COVID
Credits:
.50 AMA PRA Category 1 Credit(s) .50 AAPA Category 1 Self-Assessment CME Credit(s)
Launch Date:
January 31, 2022
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

This activity is intended to meet the educational needs clinicians involved in the prevention and treatment of COVID-19 infection.

Relevant Terms:

Paul Auwaerter, MD, MBA

Sherrilyn and Ken Fisher Professor of Medicine
Clinical Director, Division of Infectious Disease
Johns Hopkins University School of Medicine Chief Medical Officer
Johns Hopkins Point of Care-Information Technology Center 
Baltimore, Maryland

Dr. Paul Auwaerter is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include Lyme disease, Epstein-Barr virus and fever of unknown origin. 

Dr. Auwaerter serves as the clinical director of the Division of Infectious Diseases. He is also the director of the Fisher Center for Environmental Infectious Diseases and the chief medical officer of the Point of Care-Information Technology (POC-IT) Center. 
 
He earned his M.D. from the Columbia University College of Physicians and Surgeons. 
 
His research interests include tick-borne diseases and point of care information technology.
 
Dr. Auwaerter serves on the Clinical Compensation Subcommittee for the Johns Hopkins Department of Medicine. He was recognized with a Healthnetworks Service Excellence Award in 2014. He is a member of the American Society of Microbiology and the Infectious Diseases Society of America.
1. Apply understanding of the impact of COVID-19 both on patients and to the healthcare system broadly.
2. Incorporate knowledge of SARS-CoV-2 lifecycle and host responses, to the diagnosis of patients with COVID-19.
3. Manage and prevent the short and long-term complications of COVID-19 more effectively.
4. Use knowledge of key COVID-19 co-morbidities and patient-specific characteristics that affect associated morbidity and mortality to better manage these patients.

   

in collaboration with 

 

Severe Covid Infection: Patient Characteristics, Outcome Indicators and Long COVID

Presented by: Johns Hopkins School of Medicine and American Academy of Physician Associates (AAPA) 

Release Date: January 31, 2022                                                     

Expiration Date: November 30, 2022

Estimated time to complete this activity: 30 minutes. This activity has been approved for a maximum of 0.50 AMA PRA Category 1 Credits™ and 0.50 AAPA Category 1 Self-Assessment CME credit.

Fees and Prerequisites: There are no fees or prerequisites.

Acknowledgement of Commercial Support: Supported by an independent educational grant from Pfizer. 

Target Audience

This activity is intended to meet the educational needs clinicians involved in the prevention and treatment of COVID-19 infection.

Learning Objectives

 After participating in this activity, learners will demonstrate the ability to:

  • Apply understanding of the impact of COVID-19 both on patients and to the healthcare system broadly.
  • Incorporate knowledge of SARS-CoV-2 lifecycle and host responses, to the diagnosis of patients with COVID-19.
  • Use knowledge of key COVID-19 co-morbidities and patient-specific characteristics that affect associated morbidity and mortality to better manage these patients.
  • Manage and prevent the short and long-term complications of COVID-19 more effectively.

Accreditation Statement

The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

 

 

Credit Designation Statement  

The Johns Hopkins University School of Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Accreditation Statement   

    

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 Self-Assessment CME credit. PAs should only claim credit commensurate with the extent of their participation. Approval is valid through February 4, 2023

Other Credits

American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.

American Association of Nurse Practitioners National Certification Program accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

Statement of Need

While the early and uncertain stages of the COVID-19 pandemic have subsided, we now enter a phase of increasing vaccinations and deeper learning about effective treatment. These preventative measures and treatments for active infection are essential to staunch further mutations of the coronavirus. In speaking with physicians and reviewing the emerging literature, several gaps in knowledge for diagnosing and treating COVID-19 still exist. These encompass (1) the initial stages of disease and knowledge of the viral lifecycle, which impact diagnostic testing, (2) patient characteristics and co-morbidities that put patients with COVID-19 at greater risk for poor outcomes, (3) the short- and long-term impact of post-COVID-19 sequelae, and (4) the management and treatment of COVID-19 infection. Through this educational initiative, clinicians will cover these topics and gain a deeper understanding of the SARS-CoV-2 virus and to clarify their pivotal role in diagnosing and managing patients with COVID-19. 

Faculty:

Paul G. Auwaerter, MD, MBA, FIDSA
Sherrilyn and Ken Fisher Professor of Medicine
Clinical Director, Division of Infectious Diseases
Johns Hopkins School of Medicine 

Chief Medical Officer
Point of Care-Information Technology (POC-IT) Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

Policy on Speaker and Provider Disclosure

It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve conflicts of interest prior to this educational activity. Detailed disclosure will be made prior to presentation of the education.

Johns Hopkins Statement of Responsibility

The Johns Hopkins School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Copyright

All rights reserved - The Johns Hopkins School of Medicine and American Academy of PAs. No part of this program may be used or reproduced in any manner whatsoever without written permission except in the case of brief quotations embodied in articles or reviews.

Format and Method of Participation

Review this internet-based CME activity. To take the post-test, please click on the post-test button below the video window of the player which will take you to the Johns Hopkins School of Medicine’s website. If you already have registered for other programs at this website, simply enter the requested information when prompted. Otherwise, complete the registration form to begin the testing process. The information you enter here will be used to generate your CME certificate. Please complete all fields to ensure accurate registration. Complete the post-test and evaluation and attest to the amount of time spent in the activity. Upon receiving a score of 70% or above, print your CME certificate.

Full Disclosure Policy Affecting CME Activities

As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity sponsored by OCME. 

It is the policy of AAPA to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member has with the commercial interest of any commercial product discussed in an educational presentation. 

The following relationships have been reported for this activity:

Faculty

Paul Auwaerter, MD – Consulting Fee: EMD Serono, Humanigen (DSMB), Pfizer, Inc.; Stocks or stock options, excluding diversified mutual funds: Johnson and Johnson

Johns Hopkins University School of Medicine

No planner has indicated that they have any financial interest or relationships with a commercial entity.

American Academy of PAs

Daniel Pace and Cheryl Holmes have no relevant financial relationships to disclose.

Activity Planners

The following Medical Logix, LLC planners/managers Megan Gentile, John Gentile and Joshua Hwang, MD have no relevant financial relationships to disclose.

Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

Off-Label Discussion 

There are no references to off-label/unapproved uses of products in this program.

Disclaimer

The opinions and recommendations expressed by faculty and other experts, whose input is included in this program are their own. This enduring material is produced for educational purposes only. Use of the Johns Hopkins School of Medicine and American Academy of PAs name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combinations of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

CONFIDENTIALITY DISCLAIMER FOR CME ACTIVITY PARTICIPANTS

I certify that I am participating in a Johns Hopkins School of Medicine and American Academy of PAs CME activity for accredited training and/or educational purposes.

I understand that while I am participating in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the "Privacy Regulations"). Protected health information is information about a person’s health or treatment that identifies the person.

I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (e.g. Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.

I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-614-9900
e-mail: HIPAA@jhmi.edu. 

“The Office of Continuing Medical Education at the Johns Hopkins School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is attending for training, education and/or observation purposes only.”

For CME Questions, please contact the CME Office
410-955-2959 or e-mail cmenet@jhmi.edu.

For CME Certificates, please call (410) 502-9634.

Johns Hopkins School of Medicine 
Office of Continuing Medical Education
Turner 20/720 Rutland Avenue
Baltimore, Maryland 21205-2195

Reviewed & Approved by:
General Counsel, Johns Hopkins Medicine (4/1/03)
(Updated 4/09 and 3/14)

AMERICANS WITH DISABILITIES ACT

The Johns Hopkins School of Medicine and American Academy of PAs fully complies with the legal requirements of the ADA and the rules and regulations thereof. Please notify us if you have any special needs.

In cooperation with Medical Logix, LLC.

© 2021. All rights reserved – The Johns Hopkins University School of Medicine and American Academy of PAs.

COURSE VIEWING REQUIREMENTS

 

Supported Browsers:
Microsoft Edge
Google Chrome 60 or higher
Mozilla Firefox 60 or higher
Apple Safari 11.0 or higher
For video, install the latest version of Quicktime.
Supported Phones & Tablets:
iOS 9.3 and higher
Android 7.0 (Nougat or higher)
Microsoft Windows 8
Chrome OS

 
Additional Recommendations and Requirements
Display Resolution & Color Depth Resolution
- 960 X 768 minimum
- 1024 X 768 recommended min.

Color Depth
- 8 bits (256 colors) minimum
- 16 bits (High colors) minimum
Audio - Microphone
- Speakers or headphones
- Audio recording support
Word Processing Software that can open, modify, and save documents in Rich Text Format (RTF). Microsoft Word and PowerPoint are recommended.